Pharmacy Medical News about Aspirin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Value of aspirin for primary prevention should be weighed carefully
American Pharmacists Association, 07/09/09

A meta-analysis of the safety and effectiveness of long-term aspirin for primary prevention of serious vascular events concluded that the benefit of occlusive event reduction should be weighed against the potential risk of a major hemorrhagic event. Aspirin for secondary prevention is often the standard of care.

<< Previous
Social and Economic Costs of Food Allergies in Europe:...

Next >>
Effects of combination therapy with perindopril and losartan on...

Efficacy of aspirin for secondary prevention in patients with peripheral artery disease
Expert Review of Cardiovascular Therapy, 10/16/09 Relevance Score: 93%

Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome
Journal of Pharmacy and Pharmacology, 11/04/09 Relevance Score: 91%

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy, 10/20/09 Relevance Score: 91%

Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease
The American Journal of Cardiology, 10/13/09 Relevance Score: 91%

Time-Dependent Effects of Low-Dose Aspirin on Plasma Renin Activity, Aldosterone, Cortisol, and Catecholamines
Hypertension, 10/12/09 Relevance Score: 89%